DM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Digitization of Clinical Pathways in Low- and Middle-Income Countries | Digitalization of Medicine in Low- and Middle-Income Countries : Paradigm Changes in Healthcare and Biomedical Research |  | 2024 | 4 | 0 | ||
| Long-term follow-up for childhood cancer survivors: the Geneva experience | Swiss medical weekly | | 2022 | 204 | 87 | ||
| Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol | BMJ open | | 2022 | 61 | 51 | ||
| Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland | BMC Medical research methodology | | 2021 | 249 | 135 | ||
| PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level | Journal of Experimental & Clinical Cancer Research | | 2019 | 316 | 416 | ||
| Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance | Therapeutic Drug Monitoring | | 2018 | 857 | 588 | ||
| The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Pharmacology | | 2017 | 617 | 238 | ||
| Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism | Oncotarget |  | 2015 | 545 | 0 | ||
| In vivo brain macromolecule signals in healthy and lioblastoma mouse models: 1H magnetic resonance spectroscopy, post-processing and metabolite quantification at 14.1 T | Journal of neurochemistry | | 2014 | 558 | 0 | ||
| Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas | Neuro-oncology | | 2012 | 700 | 0 | ||
| In vivo metabolic profiling of glioma-initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla | NMR in biomedicine | | 2012 | 613 | 0 | ||
| Marker-independent identification of glioma-initiating cells | Nature methods | | 2010 | 535 | 0 | ||
| Limits of CD133 as a marker of glioma self-renewing cells | International journal of cancer | | 2009 | 639 | 0 | ||
| EZH2 is essential for glioblastoma cancer stem cell maintenance | Cancer research | | 2009 | 644 | 0 |
